| 000 | 01027 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515121950.0 | ||
| 264 | 0 | _c20090430 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a1476-5454 | ||
| 024 | 7 |
_a10.1038/eye.2008.139 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHawker, M J | |
| 245 | 0 | 0 |
_aThe ocular side effects of vigabatrin (Sabril): information and guidance for screening. _h[electronic resource] |
| 260 |
_bEye (London, England) _cSep 2008 |
||
| 300 |
_a1097-8 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aAnticonvulsants _xadverse effects |
| 650 | 0 | 4 |
_aEpilepsies, Partial _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aVigabatrin _xadverse effects |
| 650 | 0 | 4 |
_aVision Disorders _xchemically induced |
| 650 | 0 | 4 | _aVision Screening |
| 700 | 1 | _aAstbury, N J | |
| 773 | 0 |
_tEye (London, England) _gvol. 22 _gno. 9 _gp. 1097-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/eye.2008.139 _zAvailable from publisher's website |
| 999 |
_c17991613 _d17991613 |
||